4. Pathological diagnosis and tumor markers

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Pulmonary and digestive neuroendocrine tumors (NETs) are a group of neoplasms whose incidence and prevalence has been constantly increasing over the last years thanks to the significant improvements in instrumental diagnostic techniques. Because NETs are extremely heterogeneous a correct histopathological diagnosis is essential for appropriate treatment. More specifically, the histopathological diagnosis of NETs can be regarded as a multistep: identification of the neuroendocrine nature of the neoplasm, determination of tumor grading; identification of unknown primary. Laboratory biomarkers for the study of gastroenteropancreatic neuroendocrine tumors include both specific markers and non-specific or general markers. At the moment, chromogranin A is the best available and most frequently used biomarker for the diagnosis of NETs, offering the highest overall sensitivity. CgA has also demonstrated some utility in the assessment of response to treatment and as indicator of tumor recurrence. Free full text available at www.tumorionline.it.

Original languageEnglish
Pages (from-to)810-816
Number of pages7
JournalTumori
Volume96
Issue number5
Publication statusPublished - Sep 2010

Fingerprint

Neuroendocrine Tumors
Tumor Biomarkers
Biomarkers
Chromogranin A
Neoplasms
Neoplasm Grading
Recurrence
Lung
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

4. Pathological diagnosis and tumor markers. / Milione, Massimo; Seregni, Ettore.

In: Tumori, Vol. 96, No. 5, 09.2010, p. 810-816.

Research output: Contribution to journalArticle

@article{66704c7a141945f4b501e4111d7984bb,
title = "4. Pathological diagnosis and tumor markers",
abstract = "Pulmonary and digestive neuroendocrine tumors (NETs) are a group of neoplasms whose incidence and prevalence has been constantly increasing over the last years thanks to the significant improvements in instrumental diagnostic techniques. Because NETs are extremely heterogeneous a correct histopathological diagnosis is essential for appropriate treatment. More specifically, the histopathological diagnosis of NETs can be regarded as a multistep: identification of the neuroendocrine nature of the neoplasm, determination of tumor grading; identification of unknown primary. Laboratory biomarkers for the study of gastroenteropancreatic neuroendocrine tumors include both specific markers and non-specific or general markers. At the moment, chromogranin A is the best available and most frequently used biomarker for the diagnosis of NETs, offering the highest overall sensitivity. CgA has also demonstrated some utility in the assessment of response to treatment and as indicator of tumor recurrence. Free full text available at www.tumorionline.it.",
author = "Massimo Milione and Ettore Seregni",
year = "2010",
month = "9",
language = "English",
volume = "96",
pages = "810--816",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - 4. Pathological diagnosis and tumor markers

AU - Milione, Massimo

AU - Seregni, Ettore

PY - 2010/9

Y1 - 2010/9

N2 - Pulmonary and digestive neuroendocrine tumors (NETs) are a group of neoplasms whose incidence and prevalence has been constantly increasing over the last years thanks to the significant improvements in instrumental diagnostic techniques. Because NETs are extremely heterogeneous a correct histopathological diagnosis is essential for appropriate treatment. More specifically, the histopathological diagnosis of NETs can be regarded as a multistep: identification of the neuroendocrine nature of the neoplasm, determination of tumor grading; identification of unknown primary. Laboratory biomarkers for the study of gastroenteropancreatic neuroendocrine tumors include both specific markers and non-specific or general markers. At the moment, chromogranin A is the best available and most frequently used biomarker for the diagnosis of NETs, offering the highest overall sensitivity. CgA has also demonstrated some utility in the assessment of response to treatment and as indicator of tumor recurrence. Free full text available at www.tumorionline.it.

AB - Pulmonary and digestive neuroendocrine tumors (NETs) are a group of neoplasms whose incidence and prevalence has been constantly increasing over the last years thanks to the significant improvements in instrumental diagnostic techniques. Because NETs are extremely heterogeneous a correct histopathological diagnosis is essential for appropriate treatment. More specifically, the histopathological diagnosis of NETs can be regarded as a multistep: identification of the neuroendocrine nature of the neoplasm, determination of tumor grading; identification of unknown primary. Laboratory biomarkers for the study of gastroenteropancreatic neuroendocrine tumors include both specific markers and non-specific or general markers. At the moment, chromogranin A is the best available and most frequently used biomarker for the diagnosis of NETs, offering the highest overall sensitivity. CgA has also demonstrated some utility in the assessment of response to treatment and as indicator of tumor recurrence. Free full text available at www.tumorionline.it.

UR - http://www.scopus.com/inward/record.url?scp=78650503205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650503205&partnerID=8YFLogxK

M3 - Article

VL - 96

SP - 810

EP - 816

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 5

ER -